Embed Size (px)
Citation preview
Ehab Amir Ayoub saad AtiaPersonal information :
Sex: Male Nationality: Egyptian Date of birth: 04/13/1975 Civil status: Married Physical address: 11 St. Ahmed Nour El Din, 6th district Nasr City, Cairo Egypt Cell phone: 0020-10052-95869 Email: [email protected]
Education:
Master’s degree in microbiology, immunology and public health, faculty of pharmacy, Cairo University (October, 2013).
Bachelor of Pharmaceutical Sciences, faculty of pharmacy, Cairo University with an excellent honors grade (May, 1998).
Credit hours training in applied infectious diseases epidemiology, public health, biostatistics, and zoonotic diseases from University of Florida, college of public health (2012-13).
Training in Molecular Biology (New England Biolabs, MA, USA). Training in Microarray technology (University of York, UK). Training in Bioinformatics (Wageningen University, Netherlands). Training in Bioinformatics and Next Generation Sequencing technology (Los Alamos
Research Institute, NM, USA). Training in Bioinformatics and Next Generation Sequencing technology (Naval Medical
Research Center, MD, USA). Annual biosafety and biosecurity trainings (Naval Medical Research Unit NO.3, Cairo,
Egypt).
Professional experience:
From 2004 till now: U.S. Naval Medical Research Unit NO. 3 (NAMRU-3), Cairo, Egypt. I am currently the Head of the genomics unit at the Viral and Zoonotic Diseases Research Program (VZDRP).
Scientific duties and achievements include:
Principal investigator of several disease surveillance projects (mainly respiratory diseases) in the Middle East and West Africa to determine the prevalence of various pathogens as well as identifying and characterizing infectious agents associated with various diseases.
1
Conduct complex genomic testing of influenza and other respiratory pathogens and analyzing the resulting data using sophisticated computer programs. Constantly review the scientific landscape for new technologies and have the ability to optimize new genomic techniques to suit the current needs.
Risk assessment for public health gaps and threats through identification of possible factors which may impact the health integrity. Provide comprehensive situational analysis to monitor health threats.
Monitoring and evaluation of global emerging and re-emerging pathogens through a meticulous literature search to assess the risk, collect and analyze data.
Profound knowledge in assessment and characterization of recent diseases outbreaks like the influenza H5N1, influenza pdm 09, MERS Co-V, influenza H7N9, Ebola and ZIKA.
Presenting scientific findings to the scientific community through detailed manuscripts, abstracts and live lectures.
Established and maintained relationships and communications with public health officials and scientists in West Africa, Middle East, Eastern Europe, Central Asia and United States. Those relationships created fruitful collaboration that contributes to the global public health welfare.
Organized several workshops to train scientists and collaborators from different countries on viral diagnostics, sequencing and bioinformatics tools inside and outside NAMRU-3 that benefited nation’s public health officials. I trained over two hundred scientists and collaborators from thirty seven countries, a work that involved preparing presentations explaining the premise behind the technology and its application.
Following-up with the trained personnel to see their progress in implementing the new technology, a work that requires a lot of correspondence that involved troubleshooting of problems that might hamper their progress.
Provided technical assistance and suggested relevant control measures to different countries to enhance their capacity to develop their mitigation strategies to contain outbreaks.
Organized workshops in laboratory biosafety and biosecurity to ensure safe working environment and proper storage of infectious agents to prevent accidental access or theft of biohazard agents.
Have competent skills in the epidemiology as well as the detection and characterization of Influenza viruses, Corona viruses, Parainfluenza viruses, Enteroviruses, Rhino viruses, Human Metapneumovirus, Dengue viruses, Crimean Congo hemorrhagic fever virus, Rift Valley Fever Virus, Hepatitis viruses, Herpes viruses, Human Papilloma Viruses, ZIKA, Measles, Mumps, other Alfa and Flaviviruses and others.
Supervising four research associates, assigning tasks and ensuring timely reporting. Maintaining, upgrading and enhancing the capacity of the unit by optimizing various
assays from research publications and tailor them to the available research kits. Writing detailed standard operating procedures for laboratory assays to ensure optimum
results. Writing scientific proposals to get essential funds to execute research ideas, managed to
get funds from the Global Emerging Infectious Diseases Surveillance Program (GEIS) and the U.S Department of States.
Responding to outbreaks in different locations in the Middle East, Central Asia and Eastern Europe, being a pivotal member of an outbreak response team working under the
2
umbrella of the World Health Organization (WHO) to assess the situation, confirm the outbreak and implement necessary interventions to contain the outbreak.
Generating detailed sequence analysis reports of influenza to different collaborating countries, comprising comprehensive phylogenetic analysis of circulating strains to determine genetic clades and lineages, pointing out amino acids differences from vaccine strains as well as markers of antiviral drug resistance, and predicting alteration in antigenic and cleavage sites.
Troubleshooting problems related to the failure of PCR and sequencing reactions, responding to different questions from my subordinates concerning the use of sequence alignment and phylogenetic computer programs as well as recommending successful methods for gene sequencing and data analysis.
Responsible for the maintenance of molecular biology equipment by ordering the necessary spare parts, liaising with medical repair department, supply department and the local dealer to restore the function of the broken equipment in the shortest possible time.
Establishing reliable diagnostic laboratories in countries of limited amenities, this endeavor includes: designing the laboratory layout, ordering the biological safety cabinets and diagnostic platforms, training the staff on the basics of Good Laboratory Practices (GLP) and principles of biosafety and relevant diagnostic assays.
Establishing and maintaining collaborative relation and correspondence with scientists in many countries, thus helping in creating and developing new research projects and publications.
Participating in decision-making conventions and proposing an alternative route in case of blocked situation.
Supervising students doing their masters at NAMRU-3 by suggesting appropriate applicable assays, optimizing the assays and analyzing data.
Technical skills include :
Nucleic acid extraction from all sample types (serum, plasma, CSF, body tissues, whole blood, cell cultures, cloacal swabs, throat swabs, lymphocytes, dried spots and stool) using the classical manual methods and automated robots.
Conventional reverse transcription, nested and seminested PCR assays as well as Taqman and FRET real-time PCR assays.
Gel Electrophoresis, gel digital photography and annotation. Genetic characterization of infectious agents identified from different etiologies
(respiratory, hemorrhagic fever, and neurological) using Sanger’s and Next-Generation sequencing technologies.
Metagenomic sequencing for the purpose of pathogen discovery using Illumina platform. Data analysis using various computer programs such as Sequencher, BioEdit, MEGA,
and CLC Bio. Comparison between the genomic material of reference pathogen and a pathogen of
interest to identify the evolutionary pattern. Detecting genetic markers associated with viral altered pathogenicity and drug resistance. Generation and interpretation of phylogenetic trees to determine genetic clades and
genotypes.
3
Utilizing the National Center for Biotechnology Information (NCBI) and the Global Initiative on Sharing All Influenza Data (GISAID) web sites for downloading sequences to perform detailed phylogenetic analysis.
Submitting sequences to NCBI using BankIt and Sequin tools. Using microarray technique as a tool of pathogen discovery. Pyrosequencing to detect viral drug resistance. Functional protein assay to detect resistance of pathogens to drugs.
From September, 1999-April, 2004: Teaching assistant of pharmaceutics and industrial pharmacy at faculty of pharmacy, Cairo University, Beni Suef branch. Duties and responsibilities:
Teaching pharmacy students methods of preparation of different pharmaceutical dosage forms and drug delivery systems in a prudent manner to ensure the delivery of the calculated dose of the active ingredient via the proper route of administration to the site of action.
Training the students on patient counseling to make sure that the drug gives the required safe therapeutic effect without possible drug-drug interactions and incompatibilities.
From September, 1998-April, 2004: Processing prescriptions, dispensing, labeling and packaging of the prescribed drugs as well as patient counseling in a retail pharmacy in Cairo.
Trainings, workshops and overseas tasks:
November, 2016 (Atlanta, GA, USA): Presented an abstract about the evolution of influenza A strains in Egypt at the American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting.
September, 2016 (Lomé, Togo): Performed quality assurance assessment and conducted a control testing panel to ensure optimum performance of the central public health laboratory to detect circulating influenza strains.
September, 2016 (Nouakchott, Mauritania): Initiated a pathogen discovery study among camel workers.
August, 2016 (USA embassy, Cairo, Egypt): Attended a basic supervisory skills course. June, 2016 (Cote d’Ivoire, Abidjan): Conducted research ethics training for the personnel
involved in an Acute Febrile Illness study in the country as well as assessing the quality assurance procedures for the ongoing influenza surveillance protocol.
June, 2016 (Boston, MA, USA): Presented an abstract about the evolution of influenza B strains in Egypt at the American Society of Microbiology (ASM) annual meeting.
September, 2015 (Cote d’Ivoire, Abidjan): Initiated an Acute Febrile Illness study in the country.
August, 2015 (Atlanta, GA, USA): Presented an abstract about the evolution of influenza strains in Egypt at the International Conference on Emerging Infectious Diseases.
4
July, 2015 (Lomé, Togo): Follow up on influenza surveillance protocol and conducted a control testing panel to ensure optimum performance of the central public health laboratory.
June, 2015 (Los Alamos, NM, USA). Attended a workshop about the applications and data analysis of Next Generation Sequencing at Los Alamos laboratories.
September, 2014 (Frederic, MD, USA): Trained on data analysis of Next Generation Sequencing Technology at Naval Medical Research Centre.
August, 2014 (Cote d’Ivoire, Abidjan): Conducted a training workshop on phylogenetic analysis of influenza viruses at Pasteur institute.
June, 2014(Amman, Jordan): Conducted a refresher training workshop at the central lab on phylogenetic analysis of influenza viruses.
June, 2014 (Accra, Ghana): Conducted a refresher training workshop at the Noughi memorial institute on phylogenetic analysis of influenza viruses.
December, 2013 (Al Azhar University, Cairo): Conducted a training workshop about the role of Bioinformatics in viral diagnostics.
May, 2013 (Muscat, Oman): Conducted a training workshop to train our collaborators on Sanger’s sequencing, pyrosequencing and phylogenetic analysis of influenza viruses.
November, 2012 (Al Azhar University, Cairo): Lecturer in a workshop about the diseases caused by enteroviruses.
August, 2012 (Lomé, Togo): Troubleshooting a problem in an automated nucleic acid extractor involved in the influenza surveillance protocol.
May, 2012 (University of Florida): Attended a two-week class followed by on-line courses to obtain a certificate in emerging infectious diseases, I got “A” grade in applied epidemiology, zoonotic diseases and statistics.
April, 2012 (Amman, Jordan): Assessment of an outbreak of a viral etiology. March, 2012 (Amman, Jordan): Trained our collaborators in the central lab on
phylogenetic analysis of influenza A virus. September, 2011 (Ain Soukna, Egypt): Lecturer in a workshop about influenza
surveillance in Egypt. September, 2011 (Accra, Ghana): Trained twenty three senior and junior staff member at
the Noughi memorial institute on phylogenetic analysis of influenza viruses. August, 2011 (Wagenigen, Netherlands): Attended a training course on bioinformatics at
Wagenigen University. June 2011 (Dubai, UAE): Maintaining the efficiency of the national influenza center. May 2011 (Juba, South Sudan): Laboratory assessment to enhance the HIV diagnostic
capacity, suggesting different possible NAMRU-3 interventions to increase the diagnostic capacity of Juba laboratory services including the introduction of real-time PCR assays for HBV and HIV as well as monitoring HIV evolution and drug resistances.
March, 2011 (Rome, Italy): Presented a poster at the XIII international symposium of respiratory viral infections about an enterovirus outbreak in Egypt.
December, 2010 (NAMRU-3): Conducted and organized a two-week workshop at NAMRU-3 to train scientists from six countries in the Middle East region on phylogenetic analysis of influenza A virus for the purpose of establishing regional centers capable of molecular characterization of influenza viruses.
May, 2010 (San Diego, CA, USA): Attended the annual ASM (American Society of Microbiology) meeting.
5
August, 2009 (Amman, Jordon): Conducted a training workshop to train scientists from Iraq hosted by the Jordanian central laboratory on molecular diagnostics of respiratory viruses.
June, 2009 (Boston, MA, USA): Attended a two-week training course organized by New England Biolabs to be an accredited molecular biologist.
May, 2009 (Almaty, Kazakhstan): Conducted a training workshop to train scientists from five countries in the Central Asia region on molecular diagnostics of the 2009 Pandemic influenza.
February, 2009 (Tashkent, Uzbekistan): Conducted a training workshop to train our collaborators on real-time and conventional PCR assays for respiratory viruses and assessment of the surveillance system in place.
December, 2008 (Kabul, Afghanistan): Troubleshooting a problem in Hepatitis B real-time PCR assay.
April, 2008 (York, UK): Attended a workshop on microarray techniques and its applications at York University.
December, 2007 (Islamabad, Pakistan): Confirmation and assessment of avian influenza A H5N1 outbreak in humans.
June, 2007 (Odessa, Ukraine): Surveillance for avian influenza subtypes among migratory birds in Ukraine followed by genomic characterization of the identified subtypes at NAMRU-3.
February, 2007 (Bishkek, Kyrgyzstan): Conducted a training workshop to train our collaborators on real-time polymerase chain reaction assays for the detection of respiratory viruses and arboviruses.
November, 2006 (Kiev, Ukraine): Conducted a training workshop to train our collaborators on molecular assays to detect Arboviruses.
March, 2006 (Baku, Azerbaijan): Confirmation and assessment of the influenza A (H5N1) outbreak by establishing a mobile laboratory.
.Research manuscripts:
First author: A molecular investigative approach to an outbreak of acute hemorrhagic conjunctivitis in Egypt, October, 2010. Ehab A Ayoub, Caroline F Shafik, Anne M Gaynor, Emad W Mohareb, Magdy A Amin, Aymen S Yassin, Samir El-Refaey, Mohamed Genedy and Amr Kandeel. BMC Virology Journal 2013, 10:96.
Co-author: Aggregation of Single Nucleotide Polymorphisms in a Human H5N1 Clade 2.2 Hemagglutinin. Henry L. Niman, Magdi D. Saad, Jeffery Tjaden, Kenneth C. Earhart, Marshall R. Monteville, Mona M. Aly, Moustafa M. Mansour, Nasr El-Sayed , Ahmed E. Nayel, Ahmed S. Abdelghani, Hala M. Esmat, Emad M. Labib, Ehab A. Ayoub, Abdelattar Arafa, Gregory A. Raczniak, Mensah Agyen-Frempong , William K. Ampofo and Bruce R. Boynton. Nature Precedings : hdl:10101/npre.2007.743.2 : Posted 10 Sep 2007.
Co-author: Surveillance of avian influenza viruses in migratory birds in Egypt, 2003-09. Soliman A, Saad M, Elassal E, Amir E, Plathonoff C, Bahgat V, El-Badry M, Ahmed LS,
6
Fouda M, Gamaleldin M, Mohamed NA, Salyer S, Cornelius C, Barthel R. J Wildl Dis. 2012 Jul; 48(3):669-75.
Co-Author: Outbreak of H3N2 influenza at a US military base in Djibouti during the H1N1 pandemic of 2009. Michael T. Cosby; Guillermo Pimentel; Remington Lee Nevin; Salwa Fouad Ahmed; John D. Klena; Ehab Amir; Mary Younan; Robert Browning; Peter Sebeny. PLoS ONE, 2013:8(12).
Co-author: Phylogeny of influenza A (H7N7) and A (H9N2) viruses from migratory and domestic birds in Egypt and Saudi Arabia. Atef K. Soliman, Verina Bahgat, Zoltan Kis, Ehab Amir, Magdi Saad, Emad Elassal, Natosha Simpson, Luay Ahmed, Nancy Gerloff, Pierre Rivailler, Todd Davis, Ian York, Amanda Balish, Bo Shu, Steve Lindstrom, Alexander Klimov, Samuel Yingst, Carlos De Mattos, Emad Mohareb, Ruben Donis.
Under publication.
Acknowledgement: Microevolution of Highly Pathogenic Avian Influenza A (H5N1)
isolated from Humans, Egypt 2007-2011. Mary Younan, Mee Kian Poh, Emad Elassal, Todd Davis, Pierre Rivailler, Amanda L. Balish, Natosha Simpson, Joyce Jones, Varough Deyde, Rosette Loughlin, Ije Perry, Larisa Gubareva, Maha A. ElBadry, Shaun Truelove, Anne M. Gaynor, Emad Mohareb, Magdy Amin, Claire Cornelius, Guillermo Pimentel, Kenneth Earhart, Amel Naguib, Ahmed S. Abdelghani, Samir Refaey, Alexander I. Klimov, Ruben O. Donis, Amr Kandeel Emerg Infect Dis. 2013 January; 19(1): 43–50.
Acknowledgement: MChip, a low density microarray, differentiates among seasonal human H1N1, North American swine H1N1, and the 2009 pandemic H1N1. Gary L. Heil, Troy McCarthy, Kyoung-Jin Yoon, Siyuan Liu, Magdi D. Saad, Catherine B. Smith, Julie A. Houck, Erica D. Dawson, Kathy L. Rowlen, Gregory C Gray. Influenza and Other Respiratory Viruses, 2010, 4, 411–416.
Research abstracts:
Sequence Analysis of the Influenza A (H1N1) pdm09 Virus Haemagglutinin (HA) Gene Circulating among Influenza-Like Illness (ILI) Patients in Egypt. E.A.Ayoub, Anne Gaynor, Iman Younis, Emad Mohareb, Samir El-Refaey, Mohamed Genedy, Amr Kandeel. American Society of Tropical Medicine and Hygiene meeting in 2012.
Detection and molecular characterization of human Rhinoviruses in severe acute respiratory infection in Egypt. Engy E.Habashy, Magdy A. Amin, Aymen S. Yassin, Ehab A. Ayou1, Brent L. Hous1, Maha M. Talaat. Faculty of pharmacy, Cairo University.
Molecular Characterization of the Spike Gene of the Middle East Respiratory Syndrome Coronavirus isolated in Egypt in 2014.Ehab A Ayoub, Mayar M Said, Samir El-Refaay, Mohamed Genedy, Gabriel Defang. Approved by the XVII International Symposium on Respiratory Viral Infection that was held in Vancouver, British Columbia, Canada 6-8 March 15.
7
Phylogenetic analysis of avian Influenza AH5N1 from a recent outbreak in Egypt (2014/2015)Emad Mohareb, Ehab A Ayoub, Mary Younan, Amany Sheta, Manal Labib, Samir Refai, Samir A. Nassif, Ali Abdel Hakim , Amr Kandil. Presented at the International Conference on Emerging Infectious Diseases, Atlanta, Georgia, 23-27 August 15.
Molecular Characterization and Phylogenetic Analysis of Circulating Strains of Influenza A (H1N1) pdm09 and Influenza B from 2013-2014 in Egypt.Ehab A Ayoub, Samir El-Refaay, Mohamed Genedy, Gabriel Defang. Presented at the International Conference on Emerging Infectious Diseases, Atlanta, Georgia, 23-27 August 15.
Sequence Analysis of The Hemagglutinin Gene of Influenza A H5N1 Virus From Human Cases In Egypt From November 2014-March 2015.Ehab A Ayoub, Mary Younan, Samir El-Refaay, Mohamed Genedy, Gabriel Defang, Amr Kandil and Emad Mohareb. Presented at the 1st International Meeting on Respiratory Pathogens, at the Furama RiverFront, Singapore, 2-4 Sep 2015
Full genome analysis of A(H5N1) from a human during a surge season in transmission of avian Influenza in Egypt, 2014-2015Mary Younan, Ehab A Ayoub, Amel Naguib, Gabriel Defang, Emad Mohareb, Samir Refaey, Manal Labib, Amr Kandeel. Approved by the Xth International Congress of Veterinary Virology (ESVV 2015) held by the European Society of Veterinary Virology in Montpellier, France.
Sequence analysis of Influenza B strains collected during 2014-15 in EgyptEhab A Ayoub, Mustafa A Aziz, Nirvana Nabil, Samir El-Refaay, Mohamed Genedy, Gabriel Defang, Amr Kandil and Gabriel Defang. Presented at the ASM meeting 2016 in Boston.
Sequence analysis of Influenza A H1N1 and H3N2 strains circulating during 2014-15 in Egypt.Ehab A Ayoub, Mustafa A Aziz, Nirvana Nabil, Samir El-Refaay, Mohamed Genedy, Gabriel Defang, Amr Kandil and Gabriel Defang. Presented at the ASTMH meeting 2016 in Atlanta.
Awards and certificates:
September, 2015: Letter of commendation from commanding officer, NAMRU-3 for sustained superior performance while serving as Head, genomics unit, viral and zoonotic diseases research program at U.S. Naval medical Research Unit NO.3.
June, 2015: Certificate of ICDL (International computer driving license) from faculty of pharmacy Cairo, University.
March, 2014: Letter of commendation from commanding officer, NAMRU-3, as an appreciation for conducting a workshop about the role of Bioinformatics in viral diagnostics at Al Azhar University, Faculty of medicine.
8
June, 2014: Certificate of completion of the ethics for human subject research from the Collaborative Institutional Training Initiative Program.
May, 2014: Certificate of appreciation from the Eastern Mediterranean Regional office (EMRO) of the World Health Organization for my role in facilitation and delivering the first Sub-Regional training on diagnosis of hemorrhagic fever diseases.
March, 2014: Certificate of appreciation from the Eastern Mediterranean Regional office (EMRO) of the World Health Organization for my role in facilitation and delivering the regional training on the use of real-time PCR for detection of influenza A H7N9 virus conducted at NAMRU-3.
December, 2013: Letter of Appreciation from Al Azhar University, as an appreciation for conducting a workshop about the role of Bioinformatics in viral diagnostics at Al Azhar University, Faculty of medicine.
May, 2013: Letter of commendation from commanding officer, NAMRU-3, for publishing a paper about the conjunctivitis outbreak in Egypt during October, 2010.
May, 2012: Letter of appreciation from commanding officer, NAMRU-3, as an appreciation for my endeavor in writing grant proposals, manuscript preparations as well as the influenza H5N1 assessment with the Egyptian Ministry of Health.
November, 2012: Letter of Appreciation from Al Azhar University, as an appreciation for presenting a lecture in a workshop entitled “Diseases caused by enteroviruses”.
August, 2011: Certificate from Wagenigen University, for completing a Bioinformatics workshop.
December, 2010: On the Spot Award from commanding officer, NAMRU-3, for developing and presenting a course in sequencing technology and sequence analysis at NAMRU-3 sponsored by the Eastern Mediterranean Regional office of the World Health Organization.
November, 2010: Letter of appreciation from commanding officer, NAMRU-3, for my endeavor towards the success of the Sequencing Technology workshop conducted at NAMRU-3.
October, 2010. On the Spot Award from commanding officer, NAMRU-3, for helping to identify the causative agent of an outbreak of viral conjunctivitis in both Lebanon and Egypt.
July, 2010: Letter of appreciation from commanding officer, NAMRU-3, for implementing a new sequencing assay for the 2009 pandemic influenza A (H1N1) virus, and hence giving credit to NAMRU-3 to be the first entity to submit H1N1 sequences on GenBank from the Middle East region.
May, 2010: Letter of appreciation from commanding officer, NAMRU-3, for my role in supporting the WHO/EMRO during the 2009 pandemic influenza A (H1N1) through massive testing of samples and conducting training workshops.
February, 2010: Letter of appreciation from commanding officer, NAMRU-3, for providing epidemiologic and laboratory support for over 4000 US military members participating in the Bright Star military exercise in Egypt.
October, 2009: Letter of appreciation from commanding officer, NAMRU-3, for my endeavor to ensure the success of two integrated public health workshops, one in Cairo and one in Amman, Jordan, as a result, ninety nine scientists from eight countries received valuable education and practical training related to epidemiology and laboratory methods.
9
August, 2009: Letter of appreciation from commanding officer, NAMRU-3, for conducting a series of novel H1N1 influenza molecular diagnostics workshops for eleven countries in North/West Africa and Central Asia, being directly involved with the planning and implementation of these workshops.
June, 2009: Certificate from NEW ENGLAND BioLabs, for completing a Molecular Biology course.
May, 2009: Certificate of appreciation from the World Health Organization, for my role in facilitating and delivering the inter-country training workshop on the use of PCR techniques for diagnosis and detection of influenza A (H1N1) virus.
April, 2008: Certificate from University of York, UK, for completing a microarray technology workshop.
April, 2006: On the Spot Award from commanding officer, NAMRU-3, for my endeavor during the influenza A (H5N1) outbreak in Azerbaijan.
Computer skills:
Excellent knowledge of Microsoft office. Competent in using the phylogentic analysis programs like sequencher, BioEdit, MEGA
and CLC Bio. Using SPSS in data analysis. BankIt and Sequin for uploading sequences on GenBank.
References:
Dr. Magdi Saad Samman, technical advisor at influenza surveillance division at WHO, Geneva. Email: [email protected]. Phone: +41795959644.
Dr. Emad Mohareb, senior scientist at NAMRU-3. Email: [email protected]. Phone: +201223798320.
Dr. Aymen Yassin, Professor at microbiology department, faculty of pharmacy, Cairo University. Email: [email protected]. Phone: +201009610341.
10
